Grants and Contracts Details
| Status | Finished |
|---|---|
| Effective start/end date | 9/15/17 → 8/22/19 |
DS1040-ASSENT: A Phase 1B/2, Multi-Center, Double-Blind, Placebo-Controlled, Randomized, Single-Ascending Dose Study to Assess the Safety, Pharmacokinetics, and Pharmacodynamics of DS-1040B in Subjects with Acute Ischemic Stroke
- Pettigrew, Luther (PI)